| Main centres: | 1-3 business days |
| Regional areas: | 3-4 business days |
| Remote areas: | 3-5 business days |
Introducing Retatrutide a next-generation therapy for chronic weight management.
Unlike single-hormone treatments, Retatrutide works through three natural metabolic pathways to promote fat loss, improve glycemic control, and support liver health.
A new standard in metabolic medicine.
It is the best weightloss treatment for your " animal" if you want to do research. 🤣
Can be used as a nasal spray and injectable.
I have lost 15 kg in 12 weeks on
Based on Phase 2 and Phase 3 clinical trial data, the medical benefits of Retatrutide extend significantly beyond weight loss to include the following key areas:
· Glycemic Control: Reduces HbA1c by up to 2.0% . Up to 46% of patients achieved normoglycemia (HbA1c < 5.7%) in a Phase 3 trial .
· Weight Reduction: Delivers substantial weight loss; 24.2% at 48 weeks (Phase 2) and 30.3% (~85 lbs) at 104 weeks (Phase 3) .
· Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): In a Phase 2 substudy, it reduced liver fat by 82.4% , with 86% of patients achieving normal liver fat levels (<5%) .
· Cardiovascular Risk Factors: Significantly improves multiple markers. Phase 3 data shows reductions in triglycerides (up to 41% ), systolic blood pressure (up to 12.3 mm Hg ), and non-HDL cholesterol (up to 24.2% ) .
· Obstructive Sleep Apnea (OSA): Reduced the apnea-hypopnea index by 60.6% (36.1 events/hour) in patients with moderate-to-severe OSA .
· Knee Osteoarthritis Pain: Reduced WOMAC pain scores by 73.1% (4.3 points) from a baseline of 6.0 .
Retatrutide is an investigational triple agonist that targets GIP, GLP-1, and glucagon receptors . Regarding safety, the side effect profile is consistent with the GLP-1 class, primarily gastrointestinal issues like nausea, vomiting, and diarrhea . A newly reported side effect is urinary tract infections (UTIs), though the clinical significance is still being evaluated .
Disclaimer:
This product, Retatrutide, is strictly sold as a research compound only. It is not intended for human consumption, diagnostic, therapeutic, or medical use. I am not a medical professional, and I do not provide medical advice of any kind. By purchasing this product, you acknowledge that you are a researcher and that you assume full responsibility for its lawful, laboratory-use-only handling. No claims of safety or efficacy for human use are stated or implied. In accordance with applicable laws and regulations, this product should not be used in humans, including self-administration.
